JBJS Author Insights: Dr. Ran Schwarzkopf
Co-author Ran Schwarzkopf, MD, MSc discusses the new JBJS study “Tranexamic Acid Is Safe in Patients with a History …
Co-author Ran Schwarzkopf, MD, MSc discusses the new JBJS study “Tranexamic Acid Is Safe in Patients with a History …
Along the spectrum of early and late adopters in medicine, most orthopaedic surgeons fall in the middle. They wait for …
Every month, JBJS publishes a review of the most pertinent and impactful studies published in the orthopaedic literature during the …
The recent orthopaedic literature, including a 2017 JBJS study, provides substantial evidence that oral and intravenous tranexamic acid (TXA) …
The evidence favoring tranexamic acid (TXA) for reducing surgical blood loss is ample and growing, but until now robust data …
Prior research has established that total hip arthroplasty (THA), in and of itself, is associated with a small increased risk …

Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature …
Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature …
Most surgeons agree that tranexamic acid (TXA) is effective at reducing blood loss associated with a variety of surgical procedures, …